Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 14 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (5)
P 1 (6)
P 2 (1)

Trial Status

Completed5
Recruiting4
Not Yet Recruiting2
Active Not Recruiting2
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT07553260Not ApplicableNot Yet Recruiting

Effectiveness of 0.9% Normal Saline Soaking in Managing Acute Radiation Dermatitis

NCT02568267Phase 2Active Not Recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT07374848Phase 1Recruiting

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

NCT07276867Not ApplicableRecruiting

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

NCT07027423Phase 1Not Yet Recruiting

BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas

NCT06156410Phase 1Recruiting

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

NCT04140526Phase 1Active Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT06829654Not ApplicableRecruitingPrimary

Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors

NCT01291420Phase 1Completed

Dendritic Cell Vaccination for Patients with Solid Tumors

NCT05827458CompletedPrimary

An Adequate Cost Effective Follow Up Protocol For Bone and Soft Tissue Sarcomas

NCT04648826Phase 1WithdrawnPrimary

Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies

NCT00923325CompletedPrimary

Blood and Tissue Study of Patients in NIH Protocol 08-C-0800

NCT00754286Not ApplicableCompleted

A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer

NCT00847366Not ApplicableCompleted

Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma

Showing all 14 trials

Research Network

Activity Timeline